Pharmafile Logo
Pharmafocus logo
Advanced Search

Amylin

Showing 10 posts of 10 posts found.

dan_bradbury

Profil Institute hires former Amylin chief executive

November 6, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amylin, profil institute

Clinical research firm Profil Institute has appointed former Amylin chief executive Dan Bradbury to its Board of directors.  “Dan Bradbury …

Appointment
AZ image

AstraZeneca and BMS buy Amylin for $7 billion

July 2, 2012
Sales and Marketing Amylin, AstraZeneca, BMS

AstraZeneca and Bristol-Myers Squibb have struck a deal to purchase diabetes specialist Amylin in a complicated agreement worth $7 billion. …

News

Amylin withheld safety data, says FDA

June 27, 2012
Research and Development, Sales and Marketing Amylin, Bydureon, Byetta, FDA, lilly

The US medicines regulator says Amylin held back data relating to the safety of its diabetes drug Bydureon. The allegation …

News

Amylin dismisses BMS acquisition deal

March 30, 2012
Manufacturing and Production, Sales and Marketing Amylin, BMS, Bydureon, diabetes, lilly

Amylin Pharmaceuticals has rebuffed a $3.5 billion unsolicited takeover bid from Bristol-Myers Squibb, according to reports. Shares in Amylin rose …

News
Lilly HQ picture

Amylin to pay up to $1.6 billion to sever ties with Lilly

November 8, 2011
Research and Development, Sales and Marketing Amylin, Bydureon, Byetta, R&D, lilly

Amylin will pay up to $1.6 billion to end its diabetes pact with Lilly after a difficult year for the …

News

Byetta approved for use with insulin

October 19, 2011
Amylin, GLP-1, diabetes, lilly

The FDA has approved the use of Lilly and Amylin’s diabetes treatment Byetta as an add-on therapy to insulin glargine.The …

News

Takeda and Amylin stop obesity trial

August 8, 2011
Research and Development, Sales and Marketing Amylin, Takeda

Takeda and Amylin have decided to halt further studies of its combination treatment for obesity, due to ‘evolving dynamics’ within …

News
Eli Lilly and Company

Lilly accused of anti-competitive practices

May 17, 2011
Amylin, Boehringer, diabetes, exenatide, lilly, linagliptin

Amylin Pharmaceuticals is suing Eli Lilly and Company for alleged anticompetitive activity around Lilly’s January agreement with Boehringer Ingelheim to …

News
Obesity

Takeda obesity drug falters at phase II

March 18, 2011
Research and Development Alli, Amylin, Contrave, Meridia, Qnexa, Takeda, Xenical, lorcaserin, metreleptin, obesity, pramlintide

Yet another investigational drug appears to have faltered on the rocky path to develop anti-obesity treatments. Takeda Pharmaceutical Company and …

News
Novo Nordisk's Victoza

Novo’s Victoza beats Bydureon in head-to-head trial

March 4, 2011
Research and Development, Sales and Marketing Alkermes, Amylin, Byureon, Victoza, diabetes, exenatide, lilly, type II diabetes

Bydureon has been outperformed by rival Victoza in a head-to-trial, decimating shares in its co-developer Amylin and Alkermes, the company …

News
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026